Scrub review refers to a systematic examination of clinical study data to ensure accuracy, completeness, and regulatory compliance before database lock. This process is critical for maintaining data integrity, supporting reliable analysis, and reducing risk in late-stage development.
Effective scrub review aligns with global data quality standards and strengthens the evidence base for regulatory submissions and strategic decisions.
| Objective | Key Activities | Ownership | Timing |
|---|---|---|---|
| Validate dataset completeness | Missing data checks, expected ranges, protocol deviations | Data Manager | Ongoing, with formal review prior to lock |
| Ensure subject level accuracy | Concomitant medication checks, AE consistency, lab values | Clinical Reviewer | During database maintenance, pre-lock |
| Confirm regulatory and quality compliance | SDTM adherence, ICH GCP requirements, audit trail review | QA/Data Integrity | Pre-submission and at database lock |
| Support analysis readiness | Variable mapping, flagging outlying records, documentation | Statistical Programming | Final pre-analysis validation |
Protocol Deviations and Their Impact on Data Quality
Identifying and Classifying Deviations
Scrub review pays close attention to protocol deviations, documenting both minor and major events. Classifying deviations by severity and impact allows teams to prioritize reviews where patient safety or data validity could be affected.
Mitigation Strategies and Trend Analysis
Tracking deviations across sites and time helps uncover systemic issues. During scrub review, analysts evaluate mitigation actions such as additional training, process updates, or enhanced monitoring to prevent recurrence.
Subject Level Data Integrity Checks
Key Verification Points for Each Subject
Consistent subject level checks include enrollment verification, treatment exposure alignment, and reason for discontinuation reconciliation. These steps confirm that each participant record is complete and consistent with the protocol.
Concomitant Medication and Concomitant Disease Review
Reviewers cross check concomitant medications against allowed therapies and exclusion criteria. Similarly, concomitant disease history is validated to ensure proper baseline characterization and to assess potential confounding effects.
Adverse Event and Concomitant Safety Evaluation
AE Consistency and Expectedness Assessment
Scrub review evaluates the expectedness of adverse events, timing relative to dosing, and alignment with the expected safety profile. This process supports accurate labeling implications and risk management planning.
Laboratory and Vital Signs Correlation
Laboratory and vital signs data are reviewed for physiologic plausibility and temporal consistency. Investigators verify that flagged values are explainable and that critical safety trends are highlighted appropriately.
Data Standards, Metadata, and Regulatory Alignment
SDTM and Controlled Terminology Usage
Scrub review verifies that variables are mapped to SDTM domains with correct controlled terminology. Standardized metadata supports interoperability with regulators and speeds up submission preparation.
Audit Trail and Version Control Practices
Reviewers examine audit trails to track who made changes, when, and why. Version control ensures that analysis datasets reflect approved versions, reducing ambiguity during regulatory inspection.
Operationalizing Robust Data Review Practices
- Define clear review criteria aligned with protocol, SDTM, and ICH GCP
- Assign dedicated reviewers with domain and therapeutic area expertise
- Implement stepwise checks for subject level, safety, and regulatory variables
- Document all findings, decisions, and remediation plans in a traceable audit trail
- Schedule formal reviews at predefined milestones and before database lock
- Leverage automated quality checks to flag outliers and missing logic
- Coordinate cross functional reviews with biostatistics, safety, and regulatory teams
FAQ
Reader questions
How does scrub review differ from routine database checks?
Scrub review is a deeper, more targeted evaluation focused on data quality, protocol adherence, and analytical readiness, whereas routine checks often emphasize speed and basic completeness.
What are the most common findings during scrub review in late-phase studies?
Common findings include missing concomitant medication information, inconsistent AE timing, protocol deviation undercharacterization, and mismatched laboratory units or expected ranges.
Can scrub review prevent regulatory queries related to data integrity?
Yes, thorough scrub review reduces the likelihood of critical queries by confirming alignment with GCP, SDTM standards, and study protocol expectations before data submission.
How frequently should scrub review be scheduled within a development program?
Scrub review should occur at key milestones, including pre-database lock, after ongoing monitoring activities, and prior to statistical analysis and regulatory submission.